ERBB2 and breast cancer: Anthracyclines have cytostatic and cytotoxic actions with no reversible dose-dependent cardiac toxicity [5]; trastuzumab (TTZ) is a monoclonal antibody used in the treatment of HER-2-positive BC with no dose-dependent reversible toxicity [5].